PALM BEACH, Florida, January 31, 2018 /PRNewswire/ --
MarketNewsUpdates.com News Commentary
Oneof the biggest problems in health care is the difficulty of sharing medical records for patients-to-providers as well as between providers. As Medicare and private payers move toward more value-based care reimbursements, physicians need information to
Medical Innovation Holdings, Inc. (OTC: MIHI) and AMPS are announcing today that they have signed a Memo of Understanding (MOU) outlining the roles each company will support in specific initiatives allowing both companies access and acceleration to markets. AMPS will provide market leading healthcare cost containment solutions and services for the rollout of the MIHI HealthCare Sharing Organization (HCSO), a member-based coverage model. AMPS' mission is uniquely suited to MIHI's needs for national coverage. Mike Dendy, CEO AMPS, states, "We provide services designed and developed to help clients attain their goals of materially reducing healthcare costs while keeping participant members satisfied with quality healthcare benefits and optimized financial outcomes." Read this and more news for MIHI at http://www.marketnewsupdates.com/news/mihi.html Medical Innovation Holdings plans to market to the 58 million Hispanics in the USA a health care sharing model that reduces the costs of coverage while providing quality and timely access to health care services. MIHI will utilize the health care navigator services from AMPS to direct their members to appropriate and timely care on a national basis. "Utilizing a private coverage platform along with a private build out of a national care model places us in a very competitive position. AMPS is a cost containment solution that if utilized properly we can achieve substantial savings and provide more benefits to our members. Because of AMPS' solutions we can get there faster, easier, better, and less expensive than if we opted to go it alone," states Jake Sanchez, CEO, MIHI. The Company will begin a development process that will encompass business practices and work flow, systems architectural framework and development of the systems. Once the Company reaches the development phase it will then launch its marketing campaign. Expect more announcements on the development platform soon to come.
In other healthcare developments in the markets this week:
Amazon.com Inc. (NASDAQ: AMZN), Berkshire Hathaway and JPMorgan Chase & Co said on Tuesday they will form a company to cut health costs for hundreds of thousands of their U.S. employees, setting up a major challenge to an inefficient U.S. healthcare system. The move by three of the best-known U.S. business leaders - Amazon's Jeff Bezos, Berkshire's Warren Buffett and JPMorgan's Jamie Dimon - would take on the world's most expensive healthcare system, whose mounting costs have hurt corporate profits. Shares in U.S. healthcare companies fell across the board. The new, not-for-profit venture will initially focus on technology for "simplified, high-quality and transparent healthcare" for their more than 500,000 U.S. employees. They did not elaborate on their strategy, but said they are searching for a chief executive officer. Healthcare industry experts say the new entity could eventually negotiate directly with drugmakers, doctors and hospitals and use their vast databases to get a better handle on the costs of those services.
Teladoc, Inc. (NYSE: TDOC), the world's largest and most trusted provider of virtual care delivery services, announced this month the commercial availability of its integrated mobile app experience. Members can now benefit from a single, patient-centered point of access to answers for a wide array of medical needs, as the app combines the high frequency care services traditionally provided by Teladoc, along with the expert specialty medical and second opinion services of Best Doctors. Following the successful limited release to select clients in Q4 2017, the integrated app is now commercially available for all joint Teladoc and Best Doctors current and future clients.
Tenet Healthcare Corporation (NYSE: THC) closed up over 2% on Tuesday trading over 3.3 Million shares by the market close. Tenet Healthcare Corporation is a diversified healthcare services company with 125,000 employees united around a common mission: to help people live happier, healthier lives. Tenet's Conifer Health Solutions subsidiary provides technology-enabled performance improvement and health management solutions to hospitals, health systems, integrated delivery networks, physician groups, self-insured organizations and health plans.
HCA Healthcare, Inc. (NYSE: HCA) closed up just under 4% on Tuesday trading over 6.5 Million shares by the market close. HCA Healthcare, the largest U.S. for-profit hospital operator, said its quarterly revenue rose 8.7 percent as more patients were admitted to its hospitals. Hospital operators have been plagued by low patient admissions in the past few quarters, but HCA has been buying hospitals from rivals in the face of the decline in volumes. The company's shares, which were down in premarket trading before the results, reversed course to trade up 7 percent.
DISCLAIMER: MarketNewsUpdates.com (MNU) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. MNU is NOT affiliated in any manner with any company mentioned herein. MNU and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. MNU's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. MNU is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed MNU has been compensated twenty nine hundred dollars for news coverage of the current press releases issued by Medical Innovation Holdings, Inc. by a non-affiliated third party. MNU HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and MNU undertakes no obligation to update such statements.
Contact Information: Media Contact email: firstname.lastname@example.org +1(561)325-8757
Subscribe to our Free Newsletters!
Alström syndrome, a rare genetic disorder due to ALMS1 mutations, occurs in the first year of ...
Sodium zirconium cyclosilicate was approved by FDA recently to use as an oral suspension for ...
Encephalocele is a birth defect where a sac like protrusion of brain and covering membranes occurs ...View All